Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
33,289,095
-
Number of holders
-
45
-
Total 13F shares, excl. options
-
2,935,115
-
Shares change
-
-480,704
-
Total reported value, excl. options
-
$7,807,395
-
Value change
-
-$1,319,023
-
Number of buys
-
15
-
Number of sells
-
-29
-
Price
-
$2.66
Significant Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q3 2025
56 filings reported holding XBIT - XBiotech Inc. - Common Shares, no par value as of Q3 2025.
XBiotech Inc. - Common Shares, no par value (XBIT) has 45 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 2,935,115 shares
of 33,289,095 outstanding shares and own 8.82% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (819,239 shares), MILLENNIUM MANAGEMENT LLC (416,344 shares), BlackRock, Inc. (302,386 shares), GEODE CAPITAL MANAGEMENT, LLC (221,863 shares), RBF Capital, LLC (200,000 shares), MORGAN STANLEY (121,453 shares), NORTHERN TRUST CORP (81,624 shares), STATE STREET CORP (67,306 shares), DIMENSIONAL FUND ADVISORS LP (64,316 shares), and Squarepoint Ops LLC (62,159 shares).
This table shows the top 45 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.